Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. - Test2 - elhamkhani - TriplyDB

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

http://www.wikidata.org/entity/Q33853435

about

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a Lenalidomide and chronic lymphocytic leukemia Immune reconstitution in chronic lymphocytic leukemia Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemia Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells.Lymphoma: immune evasion strategies B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide.Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia Chronic lymphocytic leukemia and autoimmunity: a systematic review.The etiology of paraneoplastic autoimmunity.Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.Immunologic aspects of monoclonal B-cell lymphocytosis Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53 The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes.Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model.The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

P2860

Q24315721-C8E87A30-DFD1-41AE-BCE5-8E58009FBC52 Q26823597-81DE5F04-7ED9-44E5-9B08-AE28EE15AD2E Q26865561-17304340-BA3C-4B59-A78C-7CA27EF1CF7E Q27001318-76E02F08-0EA0-4840-84B1-FB3BC6999924 Q27003955-BF6F4A7F-B742-4964-8196-EC39C09EA445 Q27345402-D275BE0D-EFE8-4915-980B-412639430265 Q28080705-49B6B78C-14E2-4588-91A5-70B22B434A01 Q28245018-1ABA5E5C-66C9-428A-B078-7D6213B64F4F Q30538420-07331BAC-AA9E-411A-A3C3-D51D051B4A7C Q31167575-CBA59F3B-E54A-432C-90C5-5F4D43CE3627 Q33393696-D0925C25-AEF6-4245-85A5-A288A30371E4 Q33393705-0CFE1E53-7F64-45FA-A74F-206F84FBCD2A Q33621881-B11438AB-DE06-4DC6-A743-9C7CA55959D6 Q33758834-21C953A8-D0B2-42F1-B6E5-262FE8F7A8DD Q33780253-7A5273D2-566F-456A-B5E1-D288151D6106 Q33829089-FD56B0A3-37BC-4DBC-9C1D-7EAEC5D8E6B8 Q33915138-EA54AF37-2805-4AD3-A1D6-FE1185C7FD1D Q33931707-E5668307-B374-4C23-B300-3DC35E5AD115 Q34137016-64D5EDBE-5D1C-4EFF-AB78-DCA70F01DAA4 Q34374056-7F8611BB-3ACC-47AF-8D1D-4766827C6D74 Q34637731-FDAD04A1-B6B8-4E54-B7F7-9BE867019249 Q34899213-341770D8-0D94-4B00-9949-227CE10480C8 Q35001579-460BF74F-8934-4A36-A9A3-09724BB9945B Q35146081-F7BE7895-18A2-4BA2-BFF2-8AAA04E26FF9 Q35836860-157CBE79-674E-403F-A685-F3537B260DB1 Q35836864-B985F57A-4FA9-4C68-A7E8-98E09736240A Q36165173-686676F1-7F32-4E92-BF60-F30E711C0894 Q36177909-1C41C91F-4965-4248-B527-BB2D2779B0A8 Q36296595-08E40F2C-E0A1-4E5A-9B8B-947D1E017BF6 Q36315242-A859288A-A8D6-4F58-87A9-798348B2ECB3 Q36654128-495B2C0A-C54F-4F82-8B5E-4F554281E941 Q36712736-917A4735-79E7-4E73-9424-75CFE68D5DA2 Q36862410-E46D3053-9B9F-423B-9940-223CD79870CC Q36862781-40EB6E9A-5EE2-40F8-ABA9-8A660A15C0B0 Q36892616-A91B4CAD-B081-4F58-8C8F-B1BF3873159A Q37004749-7698C76A-D0A1-4C0E-A3C3-17232F554452 Q37004820-69F1367E-C07F-4CC7-91CE-40C35E249153 Q37046389-1B699DCB-0874-4766-AA6F-8B2487206790 Q37091230-15551771-BA05-455E-A5D9-BC92513F5883 Q37147838-D5F625A2-BC03-4857-9A15-EC7C49C1D162

P2860

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

http://www.wikidata.org/entity/Q33853435

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@ast

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@en

type

label

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@ast

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@en

prefLabel

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@ast

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@en

P1433

Q33853435-4A9B8BE6-95D2-44A3-A4E2-B0E51AE2961F

P1476

Q33853435-DEB11147-90FF-4975-83F4-5979AA76880A

P2093

Q33853435-2E81FBE0-7C92-41D1-8E49-D96B586C7D68

Q33853435-5D108648-99BB-44BA-92A5-70CB92EE3386

Q33853435-78994110-AE8B-4394-B25C-4DE5DC989E1E

Q33853435-FB818875-40E4-4DAA-8225-73E3596F3BD9

Q33853435-FD4F3703-D475-4EC9-B39C-2A7A0FB1BD74

P2860

Q33853435-00BB61AC-2BBB-40FD-A4F7-A929606295D9

Q33853435-065DA651-95D1-4E7A-8C46-C8A1F4356870

Q33853435-065E008E-0B51-4AA7-80B7-9D1B3A0DE3EB

Q33853435-10409235-3F86-4F30-AAE7-941AB30F3359

Q33853435-110FC29E-B58A-413F-BDC8-6D4A5EC2C4F2

Q33853435-14C095C0-7ACF-4E2D-8112-8A6A7D7B7999

Q33853435-19DEBD6E-9D83-46EF-9DB8-EE330419A96E

Q33853435-2714BB64-6068-4CE2-B67C-18C74D60CACF

Q33853435-2E96023F-0AF8-4077-AA47-590FDDBE796D

Q33853435-3DC314B5-677A-4DB1-890F-B78581B87217

P304

Q33853435-F26FA7B2-F000-41D7-AC93-AE6C14E71385

P31

Q33853435-F5E882D2-BC6F-4630-A4E6-45010F767AB6

P356

Q33853435-79712D73-63AE-40E2-8148-A43AF8C4326D

P407

Q33853435-0FCCC8AA-16B7-49ED-9B1E-097842393B86

P433

Q33853435-C203F967-B4EA-4B90-A5E9-24FF7058951C

P478

Q33853435-FEB6C465-FD6F-4A89-9EAB-121DD084B91A

P577

Q33853435-4F76430A-E18F-4C1B-9F61-5DA935CC6F1E

P5875

Q33853435-977F5200-8C60-4A1D-BCDC-A1C1E1766E9F

P698

Q33853435-E3736C42-69D7-4CBC-B376-959A7760AD84

P921

Q33853435-4930E3CD-A00B-47CD-8312-847F00F2C5E9

Q33853435-4946C8ED-98C4-4557-A048-E423B9DC7BF3

P932

Q33853435-98756F1C-6A1B-4CF9-BB53-3C48E38CC061

P356

P1433

Journal of Clinical Investigation

P1476

Chronic lymphocytic leukemia c ...... ession of CD4 and CD8 T cells.

@en

P2093

David Zahrieh

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Güllü Görgün

http://www.w3.org/2001/XMLSchema#string

John G Gribben

http://www.w3.org/2001/XMLSchema#string

Tobias A W Holderried

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of MINK, a novel member of mammalian GCK family kinases, which is up-regulated during postnatal mouse cerebral development

Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices

Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins

Expression patterns of two human genes coding for different rab GDP-dissociation inhibitors (GDIs), extremely conserved proteins involved in cellular transport

Human myosin-IXb is a mechanochemically active motor and a GAP for rho

FRL, a novel formin-related protein, binds to Rac and regulates cell motility and survival of macrophages

Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis

The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI

Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI

The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity

P304

1797-1805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24176

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7776907

http://www.w3.org/2001/XMLSchema#string

P698

15965501

http://www.w3.org/2001/XMLSchema#string

P921

P932

1150284

http://www.w3.org/2001/XMLSchema#string